Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide

Anesthesiology

Volumn 110, Issue 1, 2009, Pages 113-122

  Yu, Binglan ^a   Volpato, Gian Paolo ^a   Chang, Keqin ^a   Bloch, Kenneth D ^a   Zapol, Warren M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC ION; HEME; METHEMOGLOBIN; NITRIC OXIDE; POLYMERIZED HEMOGLOBIN; SODIUM NITRITE; THROMBOXANE B2; HEMOGLOBIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VESSEL TONE; CONTROLLED STUDY; DISEASE TRANSMISSION; HEMODYNAMICS; HYPERTENSION; LAMB; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MEAN ARTERIAL PRESSURE; METHEMOGLOBINEMIA; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; ANIMAL; BREATHING; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; LUNG; PHYSIOLOGY; SHEEP; TIME; VASOCONSTRICTION; WAKEFULNESS;

ADMINISTRATION, INHALATION; ANIMALS; HEMOGLOBINS; LUNG; NITRIC OXIDE; RESPIRATION; SHEEP, DOMESTIC; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; WAKEFULNESS;

EID: 58749115252     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318190bc4f     Document Type: Article

References (39)

1. Kresie L: Artificial blood: An update on current red cell and platelet substitutes. Proc (Bayl Univ Med Cent) 2001; 14:158-61
2. Buehler PW, Alayash AI: All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta 2008; 1784:1378-81
3. Moore EE, Johnson JL, Cheng AM, Masuno T, Banerjee A: Insights from studies of blood substitutes in trauma. Shock 2005; 24:197-205
4. Reid TJ: Hb-based oxygen carriers: Are we there yet? Transfusion 2003; 43:280-7
5. Raat NJ, Liu JF, Doyle MP, Burhop KE, Klein J, Ince C: Effects of recombinant- hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock. J Lab Clin Med 2005; 145:21-32
6. von Dobschuetz E, Hutter J, Hoffmann T, Messmer K: Recombinant human hemoglobin with reduced nitric oxide-scavenging capacity restores effectively pancreatic microcirculatory disorders in hemorrhagic shock. ANESTHESIOLOGY 2004; 100:1484-90
7. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM: Cell-free hemoglobinbased blood substitutes and risk of myocardial infarction and death: A metaanalysis. JAMA 2008; 299:2304-12
8. Krieter H, Hagen G, Waschke KF, Köhler A, Wenneis B, Brückner UB, van Ackern K: Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: Effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute. J Cardiothorac Vasc Anesth 1997; 11:3-9
9. Hess JR, MacDonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74: 1769-78
10. Cohn SM, Zieg PM, Rosenfield AT, Fisher BT: Resuscitation of pulmonary contusion: Effects of a red cell substitute. Crit Care Med 1997; 25:484-91
11. Rivera-Chavez FA, Huerta S, Brown R, York GB, Minei JP: Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC)-201 versus 7.5% hypertonic HBOC-201. J Trauma 2007; 63:1113-9
12. Lee R, Neya K, Svizzero TA, Vlahakes GJ: Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995; 79:236-42
13. Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ: Polymerized bovine hemoglobin solution as a replacement for allogenic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124:35-42
14. Winslow RM: Current status of blood substitute research: Towards a new paradigm. J Intern Med 2003; 5:508-17
15. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD: NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004; 36:685-97
16. Hermann J, Corso C, Messmer KF: Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock. ANESTHESIOLOGY 2007; 107:273-80
17. Yu B, Raher MJ, Volpato GP, Bloch KD, Ichinose F, Zapol WM: Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 2008; 117:1982-90
18. Buehler PW, D'Agnillo F, Hoffman V, Alayash AI: Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig. J Phamacol Exp Ther 2007; 323:49-60
19. Harrington JP, Gonzalez Y, Hirsch RE: Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: The role of plasma components. Artif Cells Blood Substit Immobil Biotechnol 2000; 28:477-92
20. Dorman SC, Kenny CF, Miller L, Hirsch RE, Harrington JP: Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components. Artif Cells Blood Substit Immobil Biotechnol 2002; 30: 39-51
21. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB: Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005; 115:3409-17
22. Weimann J, Ullrich R, Hromi J, Fujino Y, Clark MW, Bloch KD, Zapol WM: Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. ANESTHESIOLOGY 2000; 92:1702-12
23. Morel DR, Lowenstein E, Nguyenduy T, Robinson DR, Repine JE, Chenoweth DE, Zapol WM: Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation. Circ Res 1988; 62:905-15
24. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG: A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993; 214:11-6
25. Prielipp RC, MacGregor DA, Butterworth JF4th, Meredith JW, Levy JH, Wood KE, Coursin DB: Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. Chest 1996; 109:1291-301
26. Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS: Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 2006; 174:1042-7
27. Fratacci MD, Frostell CG, Chen TY, Wain JC Jr, Robinson DR, Zapol WM: Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. ANESTHESIOLOGY 1991; 75:990-9
28. Staub NC: Pulmonary intravascular macrophages. Annu Rev Physiol 1994; 56:47-67
29. Cannon RO 3rd, Schechter AN, Panza JA, Ognibene FP, Pease-Fye ME, Waclawiw MA, Shelhamer JH, Gladwin MT: Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001; 108:279-87
30. Hataishi R, Rodrigues AC, Neilan TG, Morgan JG, Buys E, Shiva S, Tambouret R, Jassal DS, Raher MJ, Furutani E, Ichinose F, Gladwin MT, Rosenzweig A, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M,: Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 291:H379-84
31. Lundberg JO, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7:156-67
32. Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM: Inhaled NO as a therapeutic agent. Cardiovasc Res 2007; 75:339-48
33. McMahon TJ, Doctor A: Extrapulmonary effects of inhaled nitric oxide: Role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc 2006; 3:153-60
34. Gaston B: Summary: Systemic effects of inhaled nitric oxide. Proc Am Thorac Soc 2006; 3:170-2
35. Olofsson C, Ahl T, Johansson T, Larsson S, Nellga°rd P, Ponzer S, Fagrell B, Przybelski R, Keipert P, Winslow N, Winslow RM: A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan®) in patients undergoing major orthopedic surgery. ANESTHESIOLOGY 2006; 105:1153-63
36. Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel EAM, Dube' GP, Symons J: Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. Eurointervention 2008; 3:600-9
37. Koh E, Niimura J, Nakamura T, Yamakage H, Takahashi H: Long-term inhalation of nitric oxide for a patient with primary pulmonary hypertension. Jpn Circ J 1998; 62:940-2
38. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO: Effect of nitric oxide on oxygenation and mortality in acute lung injury: Systematic review and meta-analysis. BMJ 2007; 334:779-86
39. The Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336: 597-604